Searchable abstracts of presentations at key conferences in endocrinology

ea0063p347 | Thyroid 1 | ECE2019

Management of refractory hypothyroidism with intramuscular levothyroxine: a clinical case

Timon Iciar Martin , Ruiz Inmaculada Moreno , Penalver Juan Jose Marin , Abiega Beatriz Ugalde , Pita Olalla Meizoso , Collantes Cristina Sevillano

Introduction: There are a few hypothyroid patients who are refractory to standard thyroid hormone replacement treatment and require unexpectedly high doses of levothyroxine. In addition to clinical situations where hypothyroid patients are non-compliant (pseudomalbsortion), or where there is the possibility of excipient-induced disease exacerbation, therapeutic failure may be due to impaired absorption of the administered drug. The common approach to managing patients is to es...

ea0063p756 | Thyroid 2 | ECE2019

Systematic review and meta-analysis of occurrence of other autoimmune diseases in autoimmune polyglandular syndrome type II and type III

Pham-Dobor Greta , Bajnok Laszlo , Gergics Marin , Hanak Lilla , Hegyi Peter , Marta Katalin , Mezősi Emese

Introduction: The autoimmune polyglandular syndrome (APS) is a complex, heterogeneous condition in which autoimmune diseases (AIs) of endocrine and non-endocrine organs can occur. There are four subgroups. The majority of patients are categorized as having APS II or APS III. In APS II, patients have Addison’s disease (AD) and autoimmune thyroid diseases (AITDs) or type I. diabetes mellitus (T1DM), while in the APS III, AITDs are combined with other autoimmune illnesses ex...

ea0063p1074 | Pituitary and Neuroendocrinology 3 | ECE2019

Local myofascitis: an unusual adverse reaction to lanreotide autogel injections

Hage Mirella , Marin Cristi , Bakopoulou Sophia , Marcellus Capucine De , Guyot Alexis , Gaillard Stephan , Raffin-Sanson Marie Laure , Cazabat Laure

Background: Somatostatin analogues are the mainstay medical treatment of acromegaly. Side effect of this treatment includes gastrointestinal disturbances, cholelithiasis, and local reactions at injection sites. Herein we report an unusual case of local myofascitis after one-year treatment with deep subcutaneous injections of lanreotide Autogel in a patient with acromegalo-gigantism.Clinical case: A 25-year-old man was found to have an invasive macroadeno...

ea0049ep603 | Diabetes therapy | ECE2017

Glycemic control and weight evolution in DM2 patients with canaglifozina

de Linares Lidia Urbon Lopez , Soto Cristina Crespo , Terroba Concepcion , Garrote Sara , Ventosa Marta , Marin Tomas , Cuellar Luis

In the late years ISGLT2 have became an usual choice to treat diabetes. The inhibition of the sodium-glucose co transporters (SLGT2) inhibits also the glucose reabsorption in the proximale tubule and increases the glucose excreted in the urine. Therefore hyperglycemia decreases and so does weight. This is a very convenient side effect since type 2 DM is highly associated with overweight/obesity. We show the results of HbA1c and weight evolution after starting canaglifozina 100...

ea0049ep693 | Obesity | ECE2017

Visceral vs subcutaneous white adipose depots response to insulin treatments in rats

Markelic Milica , Jankovic Aleksandra , Golic Igor , Aleksic Marija , Stancic Ana , Otasevic Vesna , Masovic Sava , Marin Marija , Korac Bato , Korac Aleksandra

: White adipose tissue (WAT) has an important role in the regulation of metabolic homeostasis. It is well known that two distinct WAT depots in mammals, subcutaneous WAT (sWAT) and visceral WAT (vWAT) display different metabolic roles and it could be presumed that exert different response to various hormones. Numerous studies revealed leading role of insulin in both fat accumulation (lipogenesis) and adipocyte differentiation (adipogenesis) although it is not clear is there a ...

ea0037ep64 | Adrenal cortex | ECE2015

Serum brain-derived neurotrophic factor in Cushing's syndrome patients

Santos Alicia , Resmini Eugenia , Barahona Ma Jose , Crespo Iris , Valassi Elena , Martinez Ma Antonia , Marin Ana , Webb Susan M

Introduction: Brain-derived neurotrophic factor (BDNF) is a protein that has been linked to several cardiovascular risk factors and bone status. Stress and corticosteroid exposure can affect BDNF levels, although this has never been studied in Cushing’s syndrome (CS). The aims of this study were to establish if BDNF levels were reduced in CS and to check possible associations to cardiovascular risk factors and bone status.Methods: 52 patients (18 ac...

ea0037ep798 | Pituitary: clinical | ECE2015

Increased serum levels of the Wnt antagonist Dicckopf-1 (DKK1) and impaired trabecular bone mineral density using QCT scan in acromegalic patients

Valassi Elena , Crespo Iris , Aulinas Anna , Urgell Eulalia , Malouf Jorge , Llauger Jaume , Marin Ana Maria , Biagetti Betina , Webb Susan M

Introduction: Acromegaly is associated with increased bone turnover and skeletal fragility. Although the GH/IGF1 system plays an important role in bone homeostasis, effects of GH excess on the Wnt signalling pathway are to be determined. Bone quantitative CT (QCT) provides a volumetric, tridimensional measure of bone mass at the trabecular and cortical level.Aim: i) To compare volumetric bone density (vBMD) using QCT in patients with acromegaly vs gender...

ea0032p288 | Clinical case reports - Thyroid / Others | ECE2013

Clinical case report: male patient with SRY-positive 46,XX testicular disorder of sex development

Dominguez-Lopez Marta , Gonzalez-Molero Inmaculada , Esteva Isabel , Gonzalo-Marin Montserrat , de Adana MSoledad Ruiz , Soriguer Federico

The 46 XX male syndrome (de la Chapelle syndrome or 46,XX testicular disorder of sex development -46,XX testicular DSD-) is a rare phenotype associated with disorder of the sex chromosomes. XX males exist in different clinical categories with ambiguous genitalia or partially to fully mature male genitalia, in combination with complete or incomplete masculinization.Clinical report: We describe the clinical, molecular, and cytogenetic findings of a 26-year...

ea0032p785 | Obesity | ECE2013

Neck circumference association with metabolic risk factors in patients undergoing neck surgery

Grizelj Danijela , Pandzic Jaksic Vlatka , Boscic Drago , Ajduk Marko , Ozegovic Ivan , Pavic Predrag , Subaric Marin , Jaksic Ozren

Adipose tissue distribution is one of the key determinants of metabolic dysfunction in obesity. Several large scale studies found that enlarged neck circumference is independently associated with cardiovascular risk.The aim of this study was to examine the association of neck circumference with metabolic risk factors in patients undergoing neck surgery.In 36 patients undergoing thyroid or vascular neck surgery we determined serum l...

ea0029p1085 | Neuroendocrinology | ICEECE2012

Panhypopituitarism treated and untreated with GH: long term evolution of echocardiographic parameters

Arnes J. Garcia , Gonzalez-Molero I. , Lopez M. Dominguez , Marin M. Gonzalo , Penafiel R. , Madero G. Fernandez

Objective: To evaluate the effects of GH on cardiac structure and function of patients with panhypopituitarism.Material and methods: We performed echocardiographic studies of patients with panhypopituitarism treated and not treated with GH at baseline and after 12 years of follow up. We collected clinical and echocardiographic data (systolic and diastolic ventricular diameter (LVEDD and DTSVI), interventricular septum thickness (IVS), left ventricular po...